Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
AcTFirst: A phase III, open-label, multi-center, randomized study comparing AAA817+ARPI versus standard of care in adult participants with PSMA-positive metastatic castration resistant prostate cancer
Study Type: Treatment
Phase: III
NCTID: NCT06855277
Principal Investigator:
Xinglei Shen
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients
Study Type: Supportive Care
Phase: III
NCTID: NCT05838716
Principal Investigator:
Elizabeth Wulff
An International, Prospective, Open-label, Multi-center, Randomized Phase III Study comparing lutetium 177Lu vipivotide tetraxetan AAA617 versus Observation to delay castration or disease recurrence in adult male patients with prostate-specific membrane antigen PSMA positive Oligometastatic Prostate Cancer OMPC
Study Type: Treatment
Phase: III
NCTID: NCT05939414
Principal Investigator:
Xinglei Shen
Implementation and Evaluation of SCIPI: A Multi-Site Pilot Randomized Controlled Trial to Improve Decision-Making and Quality of Life Among Patients with Localized Prostate Cancer
Study Type: Other
Phase: N/A
NCTID: NCT07280897
Principal Investigator:
William Parker
Docetaxel addition in Metastatic Castrate-Sensitive Prostate Cancer ASPIRE
Study Type: Treatment
Phase: III
NCTID: NCT06931340
Principal Investigator:
Elizabeth Wulff
An Open-Label, Multicenter Phase 1/2 Study to Evaluate the Safety and Efficacy of AB-3028 in Patients with Castration Resistant Prostate Cancer CRPC
Study Type: Treatment
Phase: I/II
NCTID: NCT07285694
Principal Investigator:
Saqib Abbasi
The Phase III ?High Five Trial? Five Fraction Radiation For High-Risk Prostate Cancer
Study Type: Treatment
Phase: III
NCTID: NCT05946213
Principal Investigator:
Jay Shiao
A Phase III, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator?s Choice in Participants with Chemotherapy-na�ve Metastatic Castration-resistant Prostate Cancer
Study Type: Treatment
Phase: III
NCTID: NCT07213674
Principal Investigator:
Haoran Li
HoLEP prior to Radiation Therapy for Patients with LUTS/Retention and Concurrent Prostate Cancer
Study Type: Supportive Care
Phase: N/A
NCTID: NCT03802851
Principal Investigator:
Bristol Whiles
A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study ICON study number: 0798/0661
Study Type: Treatment
Phase: II
NCTID: NCT02960022
Principal Investigator:
Rahul Parikh